RSV, pneumonia drug falls into shortage

There is not enough supply for usual ordering of ribavirin inhalation solutions, a drug for severe pediatric pneumonia cases caused by respiratory syncytial virus, according to a May 23 post from the American Society of Health-System Pharmacists. 

Advertisement

Bausch Health has one solution on long-term back order and another discontinued in October, Zydus Pharmaceuticals USA has one solution with a short expiration backordered, and Cameron Pharmaceuticals could not provide information to the ASHP. 

Zydus said it expects resupply to happen in the second half of 2023, and Bausch said it could not predict a release date.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.